pyridostigmine bromide has been researched along with Central Nervous System Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jordan, B; Jordan, K; Weber, T; Zierz, S | 1 |
| Berger, MJ; Kimpinski, K | 1 |
1 review(s) available for pyridostigmine bromide and Central Nervous System Neoplasms
| Article | Year |
|---|---|
A practical guide to the treatment of neurogenic orthostatic hypotension.
Topics: Autonomic Nervous System Diseases; Central Nervous System Neoplasms; Cholinesterase Inhibitors; Disease Management; Exercise Therapy; Feeding Behavior; Fludrocortisone; Humans; Hypotension, Orthostatic; Midodrine; Mineralocorticoids; Multiple Sclerosis; Neurodegenerative Diseases; Pyridostigmine Bromide; Stockings, Compression; Sympathomimetics; Tilt-Table Test | 2014 |
1 other study(ies) available for pyridostigmine bromide and Central Nervous System Neoplasms
| Article | Year |
|---|---|
Successful use of an immune checkpoint inhibitor in a patient with myasthenia gravis in remission.
Topics: Antineoplastic Agents, Immunological; Azathioprine; Central Nervous System Neoplasms; Cholinesterase Inhibitors; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphoma; Maintenance Chemotherapy; Middle Aged; Myasthenia Gravis; Neoplasm Recurrence, Local; Nivolumab; Prednisone; Pyridostigmine Bromide; Remission Induction; Thymectomy | 2019 |